viernes, 20 de marzo de 2020

FAQs for Opioid Use Disorder Prescribing and Dispensing in the COVID-19 Emergency

SAMHSA: Substance Abuse and Mental Health Services Administration

FAQs for Opioid Use Disorder Prescribing and Dispensing in the COVID-19 Emergency

In response to the Novel Coronavirus Disease (COVID-19) pandemic, SAMHSA is providing answers to Frequently Asked Questions regarding the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder for new and existing patients.

No hay comentarios: